- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by SEBASTIAN ROCHE
Total 3072 results
-
Hoffmann-La RocheCompletedAutism Spectrum DisorderUnited Kingdom
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaUnited States
-
Hoffmann-La RocheCompletedBladder Cancer | Pancreas Cancer | Cholangiocellular CarcinomaSpain, Italy, Netherlands, Slovakia
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheTerminatedGeographic AtrophyCanada, United Kingdom, United States, Argentina, Australia, France, Germany, Hungary, Italy, Poland, Spain, Brazil
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Italy, Korea, Republic of, Spain, Germany, Poland, Switzerland
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedCoronary Heart DiseaseNetherlands, United States, United Kingdom, Czechia
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedGranulomatosis With PolyangiitisUnited States, Canada, United Kingdom, Germany, Italy, Serbia, Turkey, France
-
Hoffmann-La RocheTerminatedGeographic AtrophyCanada, United States, Belgium, Peru, Argentina, Australia, Austria, Denmark, France, Germany, Hungary, Italy, Mexico, Netherlands, Poland, Slovakia, Spain, Switzerland, United Kingdom
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedMacular Degeneration | Macular EdemaUnited States
-
Hoffmann-La RocheCompletedBreast CancerKazakhstan, Belarus
-
Hoffmann-La RocheCompletedBasal Cell CarcinomaItaly, Czechia, Hungary, Belgium, Canada, Ireland, Mexico, Portugal, Slovenia, Spain, Turkey, Brazil, Bosnia and Herzegovina, Romania, United Kingdom, Germany, Israel, France, Greece, Russian Federation, Lithuania, Netherlands, Norway, Colomb... and more
-
Hoffmann-La RocheCompletedCervical CancerArgentina, Panama, Portugal, Spain, Turkey, Brazil, Colombia, Romania, Italy, Poland, France, Bulgaria, South Africa, Mexico, Russian Federation, Serbia, Costa Rica, Greece
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedMultiple SclerosisSpain, United States
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedHealthy ParticipantsUnited States
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedNon-Small-Cell Lung CarcinomaUnited States, Spain, France, Italy, Belgium, Korea, Republic of, Taiwan, United Kingdom, Luxembourg, Australia, Netherlands, Germany, Singapore, Denmark, Russian Federation, Sweden
-
Hoffmann-La RocheCompletedSmall Cell Lung CancerUnited States, Denmark, Spain, France, Canada
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedAdvanced Solid TumorUnited States
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicBelarus, Poland
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedInfluenza, HumanUnited States, Spain, Belgium, Poland, Germany, United Kingdom, Chile, Estonia, Hungary, Italy, France, South Africa, Mexico, Israel, Brazil, Guatemala, Czechia, Lithuania, Argentina, Bulgaria, Canada, Colombia, Latvia, Romania, Switzer... and more
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedUrinary Tract InfectionsUnited States, Serbia, Hungary, Latvia, Poland
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerFrance
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedMyelofibrosisItaly, United States, Canada, Germany
-
Hoffmann-La RocheCompletedGlioblastomaUnited Kingdom, Austria, Croatia, France, Italy, Spain, Turkey, Romania, Portugal, Canada, Greece, Sweden, Bulgaria, Estonia, Latvia
-
Hoffmann-La RocheWithdrawn
-
Hoffmann-La RocheCompletedNeoplasmsFrance, Spain, United States
-
Hoffmann-La RocheCompletedCytomegalovirus InfectionsUnited States, Belgium, United Kingdom, Canada, France, Spain, Brazil, Australia, Germany, Italy, Romania, New Zealand, Poland
-
Hoffmann-La RocheCompletedHIV InfectionsCanada, United States, Puerto Rico
-
Hoffmann-La RocheCompletedBreast CancerUnited Kingdom